| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| L5 Capital Inc. | 10%+ Owner | $936K | Jul 15, 2022 | ||
| John L. Lubniewski | President & CEO, Director | $11.3K | Dec 9, 2022 | ||
| Shaun D. McMeans | SVP, Finance & Admin. & CFO | $8.46K | Dec 9, 2022 | ||
| Byron Lawson | SVP/Chief Commercial Officer | $4.83K | Dec 9, 2022 | ||
| Laura Lee Godlewski | SVP Finance & Administration | $3.92K | Dec 9, 2022 | ||
| Stephen Barat | Senior VP of Therapeutics | $337 | Jun 8, 2023 | ||
| Christopher Kiritsy | Director | Sep 15, 2022 | |||
| Thomas W. Dubensky | Director | Aug 18, 2022 | |||
| Ann Hanham | Director | Sep 15, 2022 | |||
| James T. Lafrance | Director | Aug 18, 2021 | |||
| Harry A. George | Director | Aug 18, 2021 | |||
| Don M. Hardison | Director | Sep 15, 2022 | |||
| Lee R. McCracken | Director | Sep 15, 2022 | |||
| Michelle Renee Griffin | Director | Sep 15, 2022 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|